Insmed (INSM) PT Raised to $237 at Barclays
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $106.62 +1.79%
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 39
Rating Summary:
31 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 20 | New: 39
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on Insmed (NASDAQ: INSM) to $237.00 (from $231.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Palvella Therapeutics adds Matt Pauls to its board of directors
- China Communications Construction Co Ltd (601800:CH) PT Lowered to RMB5 at Citi
- KDDI Corp. (9433:JP) (KDDIY) PT Raised to JPY2,960 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
